
Dapova 10mg Tablet
Marketer
Genuwin Lifesciences
Salt Composition
Dapagliflozin (10mg)
Overview Dapova 10mg Tablet
Glibenclamide 10mg tablets are indicated, either singularly or in conjunction with other medications, for the management of type 2 diabetes. This medication assists in regulating elevated blood glucose characteristic of this condition, thereby mitigating the risk of associated severe complications and contributing to cardiovascular health protection. Glibenclamide 10mg tablets may be ingested with or without food, at any convenient time; however, consistent daily timing is recommended. Dosage will be determined by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation may lead to hyperglycemia and potentially severe consequences such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. The potential for dehydration exists; therefore, ample fluid intake is crucial. Practicing good hygiene is advisable to minimize the risk of genital fungal infections. Prior to commencing treatment, disclose any existing renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Individuals who are pregnant or breastfeeding should seek medical counsel before taking this medication. Excessive alcohol consumption should be avoided during treatment, as it may exacerbate certain side effects. Regular blood glucose monitoring is essential while using this medicine.
Uses of Dapova 10mg Tablet
Managing Type 2 Diabetes
Major Benefits of Dapova 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 10mg Dapova tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dapova 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapova 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 10mg Dapova tablet whole; do not crush, chew, or divide it. While this medication may be administered with or without food, consistent timing is recommended.
How Dapova 10mg Tablet works:
Dapova 10mg tablets help manage diabetes by facilitating the excretion of excess glucose via the urinary system.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Dapova 10mg tablets.
PregnancyCONSULT YOUR DOCTOR
Using Dapova 10mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Dapova 10mg tablets is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Dapova 10mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Dapova 10mg tablets are considered safe. No alteration to the Dapova 10mg tablet dosage is necessary.
What if you forget to take Dapova 10mg Tablet :
Should you forget a Dapova 10mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Dapova 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavior Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
